Jonathan T. Lim
Impact in
-
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 5
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Stephen D. Sander (4 shared papers)Jason P. Swindle (1 shared paper)Tim Bancroft (1 shared paper)Cheng Wang (1 shared paper)Susanne Stowasser (1 shared paper)Ferrán Morell (1 shared paper)Max Brosa (1 shared paper)Ingolf Griebsch (2 shared papers)
- Journals
- Journal of Managed Care & Specialty Pharmacy (2 papers)Future Oncology (2 papers)Blood (1 paper)BMC Pulmonary Medicine (1 paper)Journal of the American Heart Association (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Jonathan T. Lim
17 papers receiving 348 citations
Peers
Comparison fields: 5 of 59
- Oncology 83
- Pulmonary and Respiratory Medicine 89
- Cancer Research 38
- Pathology and Forensic Medicine 42
- Cardiology and Cardiovascular Medicine 48
Countries citing papers authored by Jonathan T. Lim
This map shows the geographic impact of Jonathan T. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan T. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan T. Lim more than expected).
Fields of papers citing papers by Jonathan T. Lim
This network shows the impact of papers produced by Jonathan T. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan T. Lim. The network helps show where Jonathan T. Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan T. Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 225 | |
| 2 | 2016 | 26 | |
| 3 | 2019 | 24 | |
| 4 | 2016 | 21 | |
| 5 | 2014 | 19 | |
| 6 | 2018 | 7 | |
| 7 | 2024 | 7 | |
| 8 | 2019 | 6 | |
| 9 | 2017 | 5 | |
| 10 | 2019 | 4 | |
| 11 | 2025 | 2 | |
| 12 | 2025 | 2 | |
| 13 | Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.(INTERACT-2) | 2013 | 1 |
| 14 | 2015 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2024 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Jonathan T. Lim
Jonathan T. Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Epidemiology and Internal Medicine, having authored 21 papers that have together received 353 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), Lung Cancer Treatments and Mutations (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Acute Ischemic Stroke Management (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Intracerebral and Subarachnoid Hemorrhage Research (1 paper), Folate and B Vitamins Research (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Oncology (83 citations), Pulmonary and Respiratory Medicine (89 citations), Cancer Research (38 citations), Pathology and Forensic Medicine (42 citations) and Cardiology and Cardiovascular Medicine (48 citations). Jonathan T. Lim has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Stephen D. Sander, Jason P. Swindle, Tim Bancroft, Cheng Wang, Susanne Stowasser, Ferrán Morell, Max Brosa, Ingolf Griebsch, Andreas Clemens and Sonja V. Sorensen. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, Future Oncology, Blood, BMC Pulmonary Medicine and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.